7 Matching Annotations
  1. Last 7 days
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
    1
    1. scibot 18 Jul 2024
      RRID:SCR_014709

      DOI: 10.1158/2767-9764.CRC-24-0252

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11247952/
  3. Dec 2023
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial
    1
    1. scibot 20 Dec 2023
      RRID:SCR_014709

      DOI: 10.1158/1078-0432.CCR-23-0229

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10722139/
  5. 52.53.155.43 52.53.155.43
    ccr-23-0229-html.html
    1
    1. scibot 01 Dec 2023
      RRID:SCR_014709

      DOI: 10.1158/1078-0432.ccr-23-0229

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/ff14fa8c7ad9abea8294fa337473afc457723345/ccr-23-0229-html.html
  6. Oct 2022
  7. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct biomarker profiles and TCR sequence diversity characterize the response to PD-L1 blockade in a mouse melanoma model
    1
    1. scibot 08 Oct 2022
      RRID:SCR_014709

      DOI: 10.1158/1541-7786.MCR-20-0881

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9533714/
  8. Sep 2021
  9. www.sciencedirect.com www.sciencedirect.com
    Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
    1
    1. scibot 10 Sep 2021
      RRID:SCR_014709

      DOI: 10.1016/j.ccell.2021.08.008

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821004487
  10. Aug 2021
  11. www.sciencedirect.com www.sciencedirect.com
    Untitled document
    1
    1. scibot 01 Aug 2021
      RRID:SCR_014709

      DOI: 10.1016/j.celrep.2018.11.009

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @scibot

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124718317558
  12. Oct 2020
  13. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
    CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
    1
    1. scibot 27 Oct 2020
      RRID:SCR_014709

      DOI: 10.1016/j.xcrm.2020.100127

      Resource: Adaptive Biotechnologies (RRID:SCR_014709)

      Curator: @Naa003

      SciCrunch record: RRID:SCR_014709

      What is this?
      RRID:SCR_014709 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    pubmed.ncbi.nlm.nih.gov/33205076/